DEVA has been a fundamentally strong pharmaceutical company based in Turkey. Despite the COVID restrictions and lockdowns the company somehow kept its growth momentum both in terms of revenue and profitability.
Recently it struggled to keep all time highs as we have seen a retracement and now YTD return is around 2%. The fundamentals are OK, vaccination campaign is doing well both in domestic and international markets. I am personally increasing my positions from the recent price level. Next status check to be done as the Q3 financials announced.
Recently it struggled to keep all time highs as we have seen a retracement and now YTD return is around 2%. The fundamentals are OK, vaccination campaign is doing well both in domestic and international markets. I am personally increasing my positions from the recent price level. Next status check to be done as the Q3 financials announced.